When Drug Meets Device

Time: 12:10 pm - 12:30 pm

Date: 13 March


The increasing use of and interest in innovative combination products – products combining a drug, device, and/or biologic – is raising significant challenges both for regulators and the industries they regulate.
Using specific case studies, this talk will present the challenges that Toxikon has overcome in drug stability studies as well as well in material characterization of drug/device products from a practical, analytical and regulatory point of view.


  • View full profile for Dr Lise VanderkelenDr Lise Vanderkelen Dep. Head Pharma Services - Toxikon Europe

« Back